Pediatrix Medical Group, Inc.
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $504.3M | $495.1M | $496.4M | $506.6M | $500.6M | $491.0M | $513.8M | $489.9M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $56.6M | $60.2M | $53.1M | $57.4M | $58.0M | $59.1M | $51.1M | $57.9M |
| Operating Income | $-157.7M | $15.9M | $-111.5M | $40.3M | $48.5M | $30.0M | $36.0M | $47.4M |
| Operating Margin | -31.3% | 3.2% | -22.5% | 7.9% | 9.7% | 6.1% | 7.0% | 9.7% |
| Interest Expense | $10.3M | $10.6M | $10.1M | $10.4M | $11.2M | $10.4M | $10.0M | $9.5M |
| Pretax Income | $-167.7M | $7.8M | $-138.9M | $30.8M | $38.9M | $20.7M | $27.8M | $38.9M |
| Income Tax Expense | $-14.7M | $3.8M | $-14.6M | $9.4M | $10.7M | $6.5M | $3.8M | $10.1M |
| Net Income | $-153.0M | $4.0M | $-124.3M | $21.4M | $28.3M | $14.2M | $29.7M | $30.7M |
| Net Margin | -30.3% | 0.8% | -25.0% | 4.2% | 5.6% | 2.9% | 5.8% | 6.3% |
| EPS (Basic) | $-1.84 | $0.05 | $-1.50 | $0.26 | $0.34 | $0.17 | $0.35 | $0.37 |
| EPS (Diluted) | $-1.84 | $0.05 | $-1.50 | $0.26 | $0.34 | $0.17 | $0.35 | $0.37 |
| Shares Outstanding (Basic) | 83.3M | 82.9M | 82.2M | 82.5M | 82.4M | 81.9M | 83.5M | 82.1M |
| Shares Outstanding (Diluted) | 83.3M | 83.3M | 82.2M | 83.0M | 82.7M | 82.3M | 84.1M | 82.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |